[1P] F. Disorders of the Nervous System 2

[1P-155] Targeting the promoter region of amyloid precursor protein by CRISPR/Cas 9 -Toward the therapeutic genome editing for Alzheimer's disease-

*Sonoko Tanaka¹, Miki Ikeda¹, Kiichiro Matsumura¹, Masahiro Sonoo¹, Fumiaki Saito¹ (1. Sch Med, Teikyo Univ, Tokyo, Japan)

Keywords:Alzheimer's disease, amyloid precursor protein, amyloid-β, CRISPR/Cas9